Author: Matrajt, Laura; Eaton, Julia; Leung, Tiffany; Brown, Elizabeth R.
Title: Vaccine optimization for COVID-19: Who to vaccinate first? Cord-id: r5vz8qyg Document date: 2021_2_3
ID: r5vz8qyg
Snippet: Vaccines, when available, will likely become our best tool to control the COVID-19 pandemic. Even in the most optimistic scenarios, vaccine shortages will likely occur. Using an age-stratified mathematical model paired with optimization algorithms, we determined optimal vaccine allocation for four different metrics (deaths, symptomatic infections, and maximum non-ICU and ICU hospitalizations) under many scenarios. We find that a vaccine with effectiveness ≥50% would be enough to substantially
Document: Vaccines, when available, will likely become our best tool to control the COVID-19 pandemic. Even in the most optimistic scenarios, vaccine shortages will likely occur. Using an age-stratified mathematical model paired with optimization algorithms, we determined optimal vaccine allocation for four different metrics (deaths, symptomatic infections, and maximum non-ICU and ICU hospitalizations) under many scenarios. We find that a vaccine with effectiveness ≥50% would be enough to substantially mitigate the ongoing pandemic, provided that a high percentage of the population is optimally vaccinated. When minimizing deaths, we find that for low vaccine effectiveness, irrespective of vaccination coverage, it is optimal to allocate vaccine to high-risk (older) age groups first. In contrast, for higher vaccine effectiveness, there is a switch to allocate vaccine to high-transmission (younger) age groups first for high vaccination coverage. While there are other societal and ethical considerations, this work can provide an evidence-based rationale for vaccine prioritization.
Search related documents:
Co phrase search for related documents- action mechanism and low coverage: 1
- action mechanism and low effectiveness: 1
- action mechanism and low vaccine: 1, 2, 3, 4
- additional intervention and low vaccination: 1
- additional result and low vaccine: 1
- long immunity and low vaccination: 1
- long immunity and low vaccine: 1, 2, 3, 4, 5, 6, 7, 8
- long protective and low coverage: 1
- long protective and low vaccination: 1
- long protective and low vaccine: 1, 2, 3, 4
- long scale and low supply: 1
- long scale and low vaccine: 1
Co phrase search for related documents, hyperlinks ordered by date